Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.
暂无分享,去创建一个
G. Wells | D. Barber | E. Toffelmire | M. Poon | B. Barrett | R. Gagnon | P. Laneuville | D. Cournoyer | H. Messner | D. Forrest | E. A. Harvey | R. Delage | B. Patterson | G. Posen